SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-015404
Filing Date
2021-11-10
Accepted
2021-11-10 09:16:02
Documents
57
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q btai-20210930x10q.htm   iXBRL 10-Q 1642356
2 EX-31.1 btai-20210930xex31d1.htm EX-31.1 17711
3 EX-31.2 btai-20210930xex31d2.htm EX-31.2 16867
4 EX-32.1 btai-20210930xex32d1.htm EX-32.1 10359
5 EX-32.2 btai-20210930xex32d2.htm EX-32.2 8727
6 GRAPHIC btai-20210930x10q006.jpg GRAPHIC 134815
  Complete submission text file 0001558370-21-015404.txt   5201079

Data Files

Seq Description Document Type Size
7 EX-101.SCH btai-20210930.xsd EX-101.SCH 27828
8 EX-101.CAL btai-20210930_cal.xml EX-101.CAL 34138
9 EX-101.DEF btai-20210930_def.xml EX-101.DEF 83613
10 EX-101.LAB btai-20210930_lab.xml EX-101.LAB 290525
11 EX-101.PRE btai-20210930_pre.xml EX-101.PRE 211867
12 EXTRACTED XBRL INSTANCE DOCUMENT btai-20210930x10q_htm.xml XML 651561
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 211394710
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences